On-Site Drug Lab equipment and reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Judicial Branch / Administrative Office of the US Courts (AOUSC) has released a DRAFT Request for Proposals (RFP) for a single Firm-Fixed Price, Indefinite Delivery Indefinite Quantity (IDIQ) contract for on-site drug lab equipment, reagents, supplies, and related services. This effort supports U.S. Probation and Pretrial Services Offices (USPPSO) nationwide. The opportunity is not set aside. Proposals for this draft RFP are due March 16, 2026.
Purpose & Scope
The contractor shall provide automated analyzers, forensic-use immunoassay reagents, controls, calibrators, supplies, consumables, maintenance, training, water systems, quality control, and a data management system capable of exporting results to all USPPSO laboratories nationwide. This includes installation, relocation, and closure support for laboratories, ensuring compliance with regulatory requirements and IT security policies. The objective is to enable USPPSO to nationally operate instrumented screening urine testing facilities.
Contract Details
- Contract Type: Firm-Fixed Price, Indefinite Delivery Indefinite Quantity (IDIQ).
- Period of Performance: A base ordering period of seven (7) years (04/15/2026 - 04/14/2033), with an optional ordering period of three (3) years (04/15/2033 - 04/14/2036) and a final six (6) month optional ordering period (04/15/2036 - 10/14/2036).
- Maximum Ordering Ceiling: $24,000,000.00.
- Guaranteed Minimum Obligation: $750.00.
- Set-Aside: None. The Judiciary is not subject to FAR or small business regulations for open market procurements.
- Incumbent: Siemens Healthcare Diagnostics, Inc.
Key Requirements
- Provide and maintain contractor-supplied laboratory equipment, including automated analyzers and water systems.
- Supply FDA-approved forensic-use immunoassay reagents for specified drugs of abuse at defined cutoff levels.
- Implement a web-based data management system fully compatible with proposed analyzers, capable of interfacing with the PACTS Drug Test Results (DTR) Component (as detailed in Attachment 3), and providing comprehensive training.
- Provide key personnel, including a Project Manager, Field Customer Service Representative, and Data Management System Designee.
- Ensure current OEM authorization documentation for all proposed equipment.
- Adhere to specific installation plans (Attachment 5) and site-specific logistical requirements (Attachment 2) for nationwide locations.
Submission & Evaluation
- Proposal Due Date: March 16, 2026, by 3:00 P.M. (Eastern).
- Submission Format: Electronic submission in Microsoft Office suite or PDF format, adhering to specific file naming conventions.
- Proposal Volumes: Technical Proposal, Price Proposal (including Attachment 1 - National Drug Lab Price Sheet), and Terms and Conditions.
- Evaluation Criteria: Award will be based on the Lowest-Priced Technically Acceptable (LPTA) proposal, considering factors such as Data Management System, Performance of Equipment, Ready-to-use Liquid Reagents, Key Personnel, and Price.
- Questions: All questions regarding the solicitation were required to be submitted in writing by February 23, 2026, using the provided template (Attachment 7).
Contact Information
- Primary: AJ Lee (aj_lee@ao.uscourts.gov)
- Secondary: Vanessa Jackson (Vanessa_Jackson@ao.uscourts.gov)